IS EVERYONE ON OZEMPIC?
Reader's Digest India|June 2024
Everything you need to know about the new diabetes drugs shaping the weight-loss revolution
Karen Robock
IS EVERYONE ON OZEMPIC?

Weight is something that I’ve thought about every single day of my adult life,” says Jennifer Blackburn*, a 49-year-old public relations professional in Toronto. Following decades of trying different diets and medications—and finding little success—in fall 2022 she started taking Ozempic, the diabetes drug that has become synonymous with celebrity weight loss.

“It has been life-changing,” she says.

US health-care providers wrote more than nine million prescriptions for Ozempic and similar drugs during the last few months of 2022, around the time Blackburn received her script. Some 890 million adults have obesity worldwide, and weight-loss drug sales are forecast to grow to as much as $100 billion by the end of the decade.

No wonder obesity medications are a hot topic. But there’s still mass confusion around who should take them, whether the potential side effects are worth it, and whether people who truly need them can access—and afford— the limited supply.

How do the new obesity drugs work?

Ozempic was approved by the FDA in 2017 for the treatment of type 2 diabetes. Once the manufacturer, Novo Nordisk, tapped into the drug’s added benefit of triggering substantial weight loss, it soon had another drug in the works: Wegovy, with a higher dose of the same active ingredient, semaglutide, was approved in 2021 for the treatment of obesity. The company also makes an oral form of semaglutide called Rybelsus for type 2 diabetes.

In addition to semaglutide, there is also tirzepatide, which is prescribed as Mounjaro for diabetes and Zepbound for obesity. (Again, the active ingredient is the same, but the drugs are prescribed under different names with slightly different doses.) Another diabetes drug, liraglutide, is marketed as Saxenda for weight loss. And dulaglutide is sold as Trulicity for diabetes management.

Bu hikaye Reader's Digest India dergisinin June 2024 sayısından alınmıştır.

Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.

Bu hikaye Reader's Digest India dergisinin June 2024 sayısından alınmıştır.

Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.

READER'S DIGEST INDIA DERGISINDEN DAHA FAZLA HIKAYETümünü görüntüle
ME & MY SHELF
Reader's Digest India

ME & MY SHELF

Siddharth Kapila is a lawyer turned writer whose writing has focussed on issues surrounding Hinduism. His debut book, Tripping Down the Ganga: A Son's Exploration of Faith (Speaking Tiger) traces his seven-year-long journey along India's holiest river and his explorations into the nature of faith among believers and skeptics alike.

time-read
2 dak  |
December 2024
EMBEDDED FROM NPR
Reader's Digest India

EMBEDDED FROM NPR

For all its flaws and shortcomings, some of which have come under the spotlight in recent years, NPR makes some of the best hardcore journalistic podcasts ever.

time-read
1 min  |
December 2024
ANURAG MINUS VERMA PODCAST
Reader's Digest India

ANURAG MINUS VERMA PODCAST

Interview podcasts live and die not just on the strengths of the interviewer but also the range of participating guests.

time-read
1 min  |
December 2024
WE'RE NOT KIDDING WITH MEHDI & FRIENDS
Reader's Digest India

WE'RE NOT KIDDING WITH MEHDI & FRIENDS

Since his exit from MSNBC, star anchor and journalist Mehdi Hasan has gone on to found Zeteo, an all-new media startup focussing on both news and analysis.

time-read
1 min  |
December 2024
Ananda: An Exploration of Cannabis in India by Karan Madhok (Aleph)
Reader's Digest India

Ananda: An Exploration of Cannabis in India by Karan Madhok (Aleph)

Karan Madhok's Ananda is a lively, three-dimensional exploration of India's past and present relationship with cannabis.

time-read
1 min  |
December 2024
I'll Have it Here: Poems by Jeet Thayil, (Fourth Estate)
Reader's Digest India

I'll Have it Here: Poems by Jeet Thayil, (Fourth Estate)

For over three decades now, Jeet Thayil has been one of India's pre-eminent Englishlanguage poets.

time-read
1 min  |
December 2024
Orbital by Samantha Harvey (Penguin Random House India)
Reader's Digest India

Orbital by Samantha Harvey (Penguin Random House India)

Samantha Harvey became the latest winner of the Booker Prize last month for Orbital, a short, sharp shock of a novel about a group of astronauts aboard the International Space Station for a long-term mission.

time-read
1 min  |
December 2024
She Defied All the Odds
Reader's Digest India

She Defied All the Odds

When doctors told the McCoombes that spina bifida would severely limit their daughter's life, they refused to listen. So did the little girl

time-read
9 dak  |
December 2024
DO YOU DARE?
Reader's Digest India

DO YOU DARE?

Two Danish businesswomen want us to start eating insects. It's good for the environment, but can consumers get over the yuck factor?

time-read
5 dak  |
December 2024
Searching for Santa Claus
Reader's Digest India

Searching for Santa Claus

Santa lives at the North Pole, right? Don't say that to the people of Rovaniemi in northern Finland

time-read
6 dak  |
December 2024